MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study (Q34415973)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study |
scientific article |
Statements
1 reference
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study (English)
1 reference
Razelle Kurzrock
1 reference
Eduardo Bruera
1 reference
Apostolia M Tsimberidou
1 reference
Aung Naing
1 reference
Filip Janku
1 reference
David S Hong
1 reference
David Hui
1 reference
Gerald S Falchook
1 reference
Sarina Piha-Paul
1 reference
Jennifer J Wheler
1 reference
Siqing Fu
1 reference
Michael Stecher
1 reference
Prasant Mohanty
1 reference
John Simard
1 reference
17 April 2014
1 reference
1 reference
Identifiers
1 reference